title: Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
abstract: Loss of heterozygosity (LOH) on 8p occurs at high frequencies in many tumor types, including colorectal carcinoma (CRC). We previously used microcell-mediated chromosome transfer (MMCT) into the CRC cell line SW620 to map a approximately 7.7-Mb colorectal cancer-suppressor region (CRCSR) at 8p22-23.1. In the current study, we transferred small fragments of this CRCSR into SW620 to refine the region further. Two microcell hybrids containing a 321- to 898-kb region around the D8S552 marker at 8p23.1 showed suppression of soft agar clonicity and tumorigenicity in athymic mice when compared to control cell lines. These data suggest that the putative colorectal tumor-suppressor gene is within this small region. We analyzed two candidate genes within this region: FLJ23749 and KIAA1456. Expression of both genes was detected in normal colonic crypt cells and in mucosa. Quantitative reverse transcriptase polymerase chain reaction showed downregulation of KIAA1456 in 9 of 12 primary colorectal tumors compared to matching normal mucosa, but normal or increased expression of FLJ23749. FLJ23749 was expressed in all CRC cell lines tested; however, KIAA1456 was downregulated in three cell lines, including SW620, and was restored in the suppressed microcell hybrids. 5'aza-2'Deoxycytidine treatment of the downregulated cell lines restored expression of KIAA1456, but bisulfite genomic sequencing did not show a correlation between promoter methylation and expression. Forty percent of the primary tumors showed LOH at this CRCSR locus, and mutation analysis revealed somatic mutations in 1 of 88 primary colorectal tumors for both KIAA1456 and FLJ23749. Despite the rarity of somatic mutations, the expression data suggest that KIAA1456 is still a candidate for the putative 8p colorectal cancer tumor-suppressor gene.
authors.affiliation: The Queensland Institute of Medical Research, Royal Brisbane Hospital, Herston, Queensland, Australia.
authors.forename: James M
authors.initials: JM
authors.lastname: Flanagan
authors.forename: Sue
authors.initials: S
authors.lastname: Healey
authors.forename: Joanne
authors.initials: J
authors.lastname: Young
authors.forename: Vicki
authors.initials: V
authors.lastname: Whitehall
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Trott
authors.forename: Robert F
authors.initials: RF
authors.lastname: Newbold
authors.forename: Georgia
authors.initials: G
authors.lastname: Chenevix-Trench
mesh_terms: D000818:Animals; D018938:Caco-2 Cells / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D002874:Chromosome Mapping / Q000379:methods*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000473:pathology; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation; D004252:DNA Mutational Analysis / Q000379:methods; D004273:DNA, Neoplasm / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D016147:Genes, Tumor Suppressor; D045325:HCT116 Cells / Q000737:chemistry / Q000378:metabolism; D019073:HT29 Cells / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D006822:Hybrid Cells; D019656:Loss of Heterozygosity / Q000235:genetics; D051379:Mice; D010641:Phenotype; D011401:Promoter Regions, Genetic / Q000235:genetics; D012509:Sarcoma / Q000473:pathology; D014162:Transfection / Q000379:methods
chemical_list: D004273:DNA, Neoplasm